• English
  • 简体中文
Login Register
Current Location: Home > Drug Registration and Acceptance subscription Help
-
-
-
Visualized Analysis Export Evaluation Conclusion Evaluation Progress
Acceptance No. Drug Name Active Ingredient Dosage Form Classification Submission Acceptance Date Manufacturers Manufacturers Review Status Status Date View
J0300216 低分子肝素钙注射液 heparin calcium Injection Chemical Drugs License Renew 2003-03-11 Certificate Completed-Pending Issued 2003-12-18 view
JTH2300077 那屈肝素钙注射液 nadroparin calcium Injection Chemical Drugs Disposable Import Drug Application 2023-03-23 Aspen Pharma Trading Ltd;Aspen China Company Limited (Guangzhou);Aspen Notre Dame De Bondeville view
JYHB2500208 那屈肝素钙注射液 nadroparin calcium Injection Chemical Drugs Supplementary Application 2025-04-09 Aspen Pharma Trading Ltd;Aspen Notre Dame De Bondeville view
JYHB2200320 那屈肝素钙注射液 nadroparin calcium Injection Chemical Drugs Supplementary Application 2022-06-23 Aspen Pharma Trading Ltd;Aspen Notre Dame De Bondeville view
JYHZ2300076 那屈肝素钙注射液 nadroparin calcium Injection Chemical Drugs License Renew 2023-02-15 Aspen Pharma Trading Ltd;Aspen Notre Dame De Bondeville view
CYHB2400877 低分子肝素钙注射液 heparin calcium Injection Chemical Drugs Supplementary Application 2024-06-25 Shenzhen Sciprogen Bio-pharmaceutical Co Ltd;Guangdong Sansheng Pharmaceutical Co Ltd view
JYHB2200322 那屈肝素钙注射液 nadroparin calcium Injection Chemical Drugs Supplementary Application 2022-06-23 Aspen Pharma Trading Ltd;Aspen Notre Dame De Bondeville view
JYHB2200657 那屈肝素钙注射液 nadroparin calcium Injection Chemical Drugs Supplementary Application 2022-12-20 Aspen Pharma Trading Ltd;Aspen Notre Dame De Bondeville view
JTH2300079 那屈肝素钙注射液 nadroparin calcium Injection Chemical Drugs Disposable Import Drug Application 2023-03-23 Aspen Pharma Trading Ltd;Aspen China Company Limited (Guangzhou);Aspen Notre Dame De Bondeville view
CYHB2450454 那屈肝素钙注射液 nadroparin calcium Injection Chemical Drugs(原6) Supplementary Application 2024-08-28 Nanjing King-Friend Biochemical Pharmaceutical Co Ltd view
CYHB2201258 那屈肝素钙注射液 nadroparin calcium Injection Chemical Drugs Supplementary Application 2022-07-25 Changzhou Qianhong Biopharma Co Ltd view
JYHZ2300077 那屈肝素钙注射液 nadroparin calcium Injection Chemical Drugs License Renew 2023-02-15 Aspen Pharma Trading Ltd;Aspen Notre Dame De Bondeville view
J0300214 低分子肝素钙注射液 heparin calcium Injection Chemical Drugs License Renew 2003-03-11 Certificate Completed-Pending Issued 2003-12-18 view
CYHS2401677 那屈肝素钙注射液 nadroparin calcium Injection Chemical Drugs(4) Generic Drug 2024-06-05 NCPC Genetech BIOTECHNOLOGY Co Ltd;North China Pharmaceutical HUAKUN Hebei BIOTECHNOLOGY Co Ltd view
JYHB2200323 那屈肝素钙注射液 nadroparin calcium Injection Chemical Drugs Supplementary Application 2022-06-23 Aspen Pharma Trading Ltd;Aspen Notre Dame De Bondeville view
CYHB2202230 肝素钙注射液 heparin calcium Injection Chemical Drugs Supplementary Application 2022-12-15 Chengdu Haidekang Pharmaceutical Co Ltd;Chengdu Hepatunn Pharmaceutical Co Ltd view
J0300215 低分子肝素钙注射液 heparin calcium Injection Chemical Drugs License Renew 2003-03-11 Certificate Completed-Pending Issued 2003-12-18 view
CYHB2450453 那屈肝素钙注射液 nadroparin calcium Injection Chemical Drugs(原6) Supplementary Application 2024-08-28 Nanjing King-Friend Biochemical Pharmaceutical Co Ltd view
CYHB2240020 那屈肝素钙注射液 nadroparin calcium Injection Chemical Drugs Supplementary Application 2022-05-12 Changzhou Qianhong Biopharma Co Ltd view
JYHB2200658 那屈肝素钙注射液 nadroparin calcium Injection Chemical Drugs Supplementary Application 2022-12-21 Aspen Pharma Trading Ltd;Aspen Notre Dame De Bondeville view